Mauritius
Mauritius
Explore linked clinical trials.8 results · Page 1 of 1
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Moka | Moka | Mauritius | 1 |
| Phoenix | Phoenix | Mauritius | 3 |
| Port Louis | Port Louis | Mauritius | 1 |
| Port Louis | Port Louis | Mauritius | 1 |
| Quatre Bornes | Quatre Bornes | Mauritius | 1 |
| Quatre Bornes | Quatre Bornes | Mauritius | 2 |
| Solferino Phoenix | Solferino Phoenix | Mauritius | 1 |
| Vacoas | Vacoas | Mauritius | 2 |
11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genetic Analysis of Uncommon Disease Presentations in Non-US Populations | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Undiagnosed Diseases | Recruiting | Not stated | 2026-10-09 | NCT06595940 | |
| Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial Vaginosis | Bacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Urogenital Diseases, bacterial infectious disease, bacterial vaginosis, candidiasis, female reproductive system disorder, fungal infectious disease, vaginal disorder, vaginitis, vulvar disease, vulvitis, vulvovaginal candidiasis, vulvovaginitis | Recruiting | Not applicable | 2026-10-02 | NCT07234786 | |
| A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Active, not recruiting | Phase 2 | 2026-09-22 | NCT06637631 | |
| Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 2 | 2026-09-22 | NCT05039840 | |
| Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Active, not recruiting | Phase 3 | 2026-08-25 | NCT05030428 | |
| The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosus | Active, not recruiting | Phase 2 | 2026-07-20 | NCT05540327 | |
| Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Erythema, Hypersensitivity, Immediate, Neurologic Manifestations, Paresthesia, Pathological Conditions, Signs and Symptoms, Pruritus, Sensation Disorders, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, Somatosensory Disorders, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, nervous system disorder, skin disorder | Recruiting | Not applicable | 2026-05-05 | NCT07014007 | |
| Comparative Study for the Evaluation of a New Medical Device Shampoo on the Treatment of Head Lice Infestation | Headlice | Not yet recruiting | Not applicable | 2026-02-10 | NCT07391059 | |
| CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON DEPIGMENTATION OF LENTIGO SPOTS | Solar Lentigo | Not yet recruiting | Not applicable | 2025-11-20 | NCT07239726 | |
| COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS | Hyperpigmentation, Melanosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Not applicable | 2025-08-20 | NCT07071363 | |
| The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Active, not recruiting | Not stated | 2025-07-17 | NCT07048717 |